Monitoring of cardiac troponin I in patients with acute heart failure

Annals of Clinical Biochemistry

Volumn 36, Issue 4, 1999, Pages 433-437

  Chen, Yi Ni ^a   Wei, Jian Rui ^a   Zeng, Li Jian ^a   Wu, Min Yi ^a  

^a GUANGZHOU RED CROSS HOSPITAL   (China)

Author keywords

Creatine kinase MB isoenzyme; Myocyte damage

Indexed keywords

CREATINE KINASE MB; TROPONIN I;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEART FUNCTION; HEART INJURY; HUMAN; MALE; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0032798640     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329903600405     Document Type: Article

References (16)

1. 1 Alonsozana LG, Christenson RH. The case for cardiac troponin T: marker for effective risk stratification of patients with acute cardiac ischemia. Clin Chem 1996; 42: 803-8
2. 2 Zhang R, Zhao J, Mandveno A, Potter JD. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 1995; 76: 1028-35
3. 3 Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38: 2203-14
4. 4 Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39: 972-9
5. 5 Cummins P, Young A, Auckland ML. Comparison of serum cardiac specific troponin I with creatine kinase, creatine kinase MB isoenzyme, tropomyosin myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma? Eur J Clin Invest 1987; 17: 317-24
6. 6 Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987; 113: 1333-4
7. 7 Adams JE, Bodor GS, Davilia-Roman VG, Delmez JA, Apple FS, Ladenson JH, et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993; 88: 101-6
8. 8 Bhagal CI, Langton P, Lewer M, Ching S, Beilby JP. Cardiac troponin I should replace CKMB for the diagnosis of acute myocardial infarction. Ann Clin Biochem 1997; 34: 511-6
9. 9 Christenson RH, Apple FS, Morgan DL, Alonsozana GL, Mascotti K, Olson M, et al. Cardiac troponin I measurement with the ACCESS Immunoassay system: analytical and clinical performance characteristics. Clin Chem 1998; 44: 52-60
10. 10 La-Vecchia L, Mezzana G, Ometto R, Bedogni F, Soffiati G, Vincenzi M. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol 1997; 80: 88-90
11. 11 Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953-8
12. 12 Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59: 607-9
13. 13 Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of system for assessing cardiovascular functional class, advantages of a new specific activity scale. Circulation 1981; 64: 1227-34
14. 14 Access Immunoassay System, User's Manual. Cardiovascular assays. Chaska MN, USA: Sanofi Pasteur Diagnostic, 1997
15. 15 Francis GS, McDonald K, Chu C, Cohn JN. Pathophysiologic aspects of endstage heart failure. Am J Cardiol 1995; 75: 11A-6A
16. 16 Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-9